PRPL vs REGN · rev $487.9M vs P/E 14, rev $14.34B
Purple Innovation Inc (PRPL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Purple Innovation Inc (PRPL) is a furnishings, fixtures & appliances company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PRPL revenue for 2024-12-31 was $487.9M. Net income was -$98.1M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. PRPL currently screens at market cap $44.9M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PRPL currently screens at market cap $44.9M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PRPL and REGN stock pages for the full models.
Not investment advice.